Taiwan FDA registration 3ce5e71cad5e79e8363d26929446d3d2
The Binding Site Optilite Albumin Kit
TW: 邦迪斯歐普羅白蛋白分析套組
Taiwan·Risk Class 2·MD·THE BINDING SITE GROUP LTD·Registered Feb 26, 2019 – Feb 26, 2024ExpiredRegistration details
- Analysis ID
- 3ce5e71cad5e79e8363d26929446d3d2
- License Form
- Ministry of Health Medical Device Import No. 032189
- Customs Code
- DHA05603218901
Company information
- Manufacturer
- THE BINDING SITE GROUP LTD
- Manufacturer Country
- United Kingdom
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- This product is used with the Binding Site Plite analyzer for in vitro quantitative analysis of human serum and plasma albumin containing heparin lithium salts or EDTA anticoagulants.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1035 Albumin Test System
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Feb 26, 2019
- Expiry Date
- Feb 26, 2024
About this record
Access comprehensive regulatory information for The Binding Site Optilite Albumin Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3ce5e71cad5e79e8363d26929446d3d2 and manufactured by THE BINDING SITE GROUP LTD. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices